Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Student Research Committee, Department and Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Biochem Genet. 2018 Oct;56(5):522-532. doi: 10.1007/s10528-018-9859-4. Epub 2018 Apr 13.
Recent genome-wide association studies (GWAS) identified a list of single-nucleotide polymorphisms (SNPs) associated with coronary artery disease (CAD). Replication of GWAS findings in different population corroborated the observed association in the parent GWAS. In this study, we aimed to replicate the association of rs1870634, a GWAS identified SNP, to CAD in an Iranian population. The study population consisted of 267 subjects undergoing coronary angiography coronary angiography including 155 CAD patients and 112 non-CAD age- and gender-matched controls. The genotype determination of rs1870634 SNP performed using high-resolution melting analysis (HRM) technique. Our results revealed that the GG genotype frequency was significantly higher in CAD patients compared with controls (P = 0.03). The results of binary logistic regression suggested that this genotype was significantly associated with CAD risk adjustment for age, BMI, sex, TC, and LDL-C lipid levels (OR of 2.78, 95% CI (1.10-7.01), P = 0.03). Moreover, our results showed that the GG+TG genotypes were 2.52 times more likely to develop CAD (95% CI 1.05-6.03) than TT genotype carriers after adjusting for age, sex, and lipid profiles (P = 0.037). These data showed that the GG genotype could be associated with increased risk of CAD in a sample of Iranian population.
最近的全基因组关联研究(GWAS)确定了一系列与冠状动脉疾病(CAD)相关的单核苷酸多态性(SNP)。在不同人群中对 GWAS 发现的复制结果证实了在母 GWAS 中观察到的相关性。在这项研究中,我们旨在复制 GWAS 确定的 SNP rs1870634 与伊朗人群 CAD 的关联。研究人群包括 267 名接受冠状动脉造影的患者,其中 155 名 CAD 患者和 112 名年龄和性别匹配的非 CAD 对照。使用高分辨率熔解分析(HRM)技术确定 rs1870634 SNP 的基因型。我们的结果表明,与对照组相比,CAD 患者的 GG 基因型频率显着升高(P = 0.03)。二元逻辑回归结果表明,该基因型与 CAD 风险显着相关,调整年龄、BMI、性别、TC 和 LDL-C 脂质水平后(OR 为 2.78,95%CI(1.10-7.01),P = 0.03)。此外,我们的结果表明,在调整年龄、性别和脂质谱后,与 TT 基因型携带者相比,GG+TG 基因型发生 CAD 的可能性增加 2.52 倍(95%CI 为 1.05-6.03)(P = 0.037)。这些数据表明,在伊朗人群样本中,GG 基因型可能与 CAD 风险增加有关。